Study of MEDI-573 Plus Standard Endocrine Therapy for Women With Hormone-sensitive Metastatic Breast Cancer

Clinical trial NCT01446159 · COMPLETED

Trial details

NCT number: NCT01446159
Sponsor: MedImmune LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone-sensitive, HER-2 Negative Metastatic Breast Cancer

Start date: 2011-06-13
Primary completion: 2019-06-28
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.